The Novel HDAC8 Inhibitor WK2-16 Attenuates Lipopolysaccharide-Activated Matrix Metalloproteinase-9 Expression in Human Monocytic Cells and Improves Hypercytokinemia In Vivo.
about
The Novel HDAC8 Inhibitor WK2-16 Attenuates Lipopolysaccharide-Activated Matrix Metalloproteinase-9 Expression in Human Monocytic Cells and Improves Hypercytokinemia In Vivo.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The Novel HDAC8 Inhibitor WK2- ...... oves Hypercytokinemia In Vivo.
@en
type
label
The Novel HDAC8 Inhibitor WK2- ...... oves Hypercytokinemia In Vivo.
@en
prefLabel
The Novel HDAC8 Inhibitor WK2- ...... oves Hypercytokinemia In Vivo.
@en
P2093
P2860
P356
P1476
The Novel HDAC8 Inhibitor WK2- ...... roves Hypercytokinemia In Vivo
@en
P2093
Chih-Kuang Chen
George Hsiao
Wei-Jan Huang
Yung-Chen Chou
P2860
P356
10.3390/IJMS18071394
P407
P577
2017-06-29T00:00:00Z